Locomotion and Global Positioning System in Arterial Disease (Starter-GPS)

This study has been completed.

Sponsor:

Collaborator:

Société Française de Médecine Vasculaire

Information provided by (Responsible Party):

University Hospital, Angers

ClinicalTrials.gov Identifier:

NCT00485147

First received: June 11, 2007

Last updated: June 28, 2012

Last verified: April 2010

History of Changes

Purpose

The maximal walking distance (MWD) performed on treadmill (TT) remains the gold standard in estimating the walking capacity of patients suffering from peripheral arterial disease (PAD) with intermittent claudication, although treadmills are not accessible to most physicians. We hypothesized that global positioning system (GPS) recordings could monitor community-based outdoor walking and provide valid information on walking capacity in PAD patients.

Condition	Intervention
Peripheral Arterial Disease	Procedure: Recording of GPS during a free walking in a public park


Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic
Official Title:	Study of Human Locomotion With Global Positioning System. Application to Patients With Peripheral Arterial Disease

Resource links provided by NLM:

MedlinePlus related topics: Peripheral Arterial Disease

U.S. FDA Resources

Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:

Validate the ability of GPS to detect walking and resting bouts and to accurately estimate walking speed and distance in normal subjects. [ Time Frame: 2 years ]
Measurement of maximal walking distance using GPS and comparison with treadmill measurement in PAD patients. [ Time Frame: 2 years ]

Secondary Outcome Measures:

Determine the variability of the walking capacity and its potential determinants in PAD patients. [ Time Frame: 3 years ]
Analyse the reliability and sensibility of GPS measurements of the walking capacity in PAD patients. [ Time Frame: 4 years ]
Analyse potential factors that could affect the accuracy of GPS measurements [ Time Frame: 4 years ]


Enrollment:	140
Study Start Date:	March 2006
Study Completion Date:	December 2010
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Intervention Details:

Analyse the clinical change after surgery from GPS measurements and compare it with laboratory measurement.

Detailed Description:

The study has two main objectives, conducted together. Each objective include several phases.

Objective 1: technical validation of GPS measurements in healthy subjects.

phase 1: technical validation of a GPS device to study outdoor walking (completed).

phase 2: comparison and use of various GPS devices (intra- and inter-GPS variability) in the study outdoor walking (on-going).

phase 3: study of several factors that could influence accuracy of GPS measurements as walking speed, environment, sampling frequency and others technical features as the WAAS/EGNOS function (on-going).

Objective 2: Application in PAD patients to study walking capacity under free-living conditions

phase 1: comparison of GPS measurements (maximal walking distance) with the gold standard treadmill measurement of maximal walking distance (completed).

phase 2: analysis of the variability of the walking capacity under free-living conditions from GPS measurements (completed).

phase 3: study of reliability and sensibility (effect of treatment) of GPS measurements (on-going).

phase 4: study of the relationship between laboratory measurements of walking capacity and GPS-derived parameters.

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Ankle to Brachial Index (ABI) < 0.95 for PAD patients
Age > 18 years old
Able to walk on treadmill

Exclusion Criteria:

limb pain of potential non-vascular origin
myocardial infraction in the last six months
uncontrolled angina pectoris

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00485147

Locations


France
Centre hospitalier universitaire
Angers, France, 49933

Sponsors and Collaborators

University Hospital, Angers

Société Française de Médecine Vasculaire

Investigators


Study Director:	Pierre Abraham, MD, PhD	Laboratory for Vascular Investigations. University Hospital. Angers. France.

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Noury-Desvaux B, Abraham P, Mahé G, Sauvaget T, Leftheriotis G, Le Faucheur A. The accuracy of a simple, low-cost GPS data logger/receiver to study outdoor human walking in view of health and clinical studies. PLoS One. 2011;6(9):e23027. doi: 10.1371/journal.pone.0023027. Epub 2011 Sep 13.

Le Faucheur A, Noury-Desvaux B, Mahé G, Sauvaget T, Saumet JL, Leftheriotis G, Abraham P. Variability and short-term determinants of walking capacity in patients with intermittent claudication. J Vasc Surg. 2010 Apr;51(4):886-92. doi: 10.1016/j.jvs.2009.10.120.


Responsible Party:	University Hospital, Angers
ClinicalTrials.gov Identifier:	NCT00485147 History of Changes
Other Study ID Numbers:	CP 2005-04
Study First Received:	June 11, 2007
Last Updated:	June 28, 2012

Keywords provided by University Hospital, Angers:


Claudication peripheral arterial disease Diagnosis	Exercise Walking impairment Disability

Additional relevant MeSH terms:


Peripheral Arterial Disease Peripheral Vascular Diseases Atherosclerosis Arteriosclerosis	Arterial Occlusive Diseases Vascular Diseases Cardiovascular Diseases

ClinicalTrials.gov processed this record on June 22, 2017

To Top